Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572195 · ClinicalTrials.gov registry record · Phase 4
RNS® System LTT Study
A Phase 4 study, sponsored by NeuroPace.
- Completed
- Registry status
- Phase 4
- Development phase
- 230
- Enrollment target
NCT00572195: Completed Phase 4 study, sponsored by NeuroPace.
NCT00572195 is a Phase 4 study that has completed, run by NeuroPace. The registered enrollment target is 230 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00572195, a Phase 4 study, has completed, sponsored by NeuroPace.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 230 participants
- Enrollment target
Study Summary
The RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures that are refractory to two or more antiepileptic medications. Candidates will continue to receive their epilepsy medications while participating in the trial.
Primary Outcome
The number of subjects having an SAE during the RNS® System LTT study.
Interventions
- DEVICE RNS® System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2006-04 |
| Est. Completion | 2018-05 |
| Phase | Phase 4 |
What the finished NCT00572195 record still lists
NCT00572195 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 1 intervention - of which RNS® System is the first listed.
NCT00572195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00572195 about?
NCT00572195 is a clinical study titled "RNS® System LTT Study". The RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures that are refractory to two or more antiepile...
What is the current status of trial NCT00572195?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 230 participants. The study started on 2006-04. Estimated completion is 2018-05.
What interventions are being tested in trial NCT00572195?
The interventions under investigation include: RNS® System (DEVICE).
Who is sponsoring clinical trial NCT00572195?
This trial is sponsored by NeuroPace, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00572195's enrollment target sits among peer trials
230 371st of 2000 higher than 1,627 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia